Tumor-inhibitory effects of combinations of the vinca alkaloids with actinomycin D.
D000818:Animals; D002286:Carcinoma, Ehrlich Tumor; D004273:DNA, Neoplasm / Q000096:biosynthesis; D003609:Dactinomycin / Q000494:pharmacology*; D004357:Drug Synergism; D051379:Mice; D009363:Neoplasm Proteins / Q000096:biosynthesis; D012334:RNA, Neoplasm / Q000096:biosynthesis; D012510:Sarcoma 180; D014529:Uridine / Q000378:metabolism; D014747:Vinblastine / Q000494:pharmacology*
D004273:DNA, Neoplasm; D009363:Neoplasm Proteins; D012334:RNA, Neoplasm; D003609:Dactinomycin; D014747:Vinblastine; D014529:Uridine